source
- FDA approves OTC naloxone nasal spray Rextovy, expanding consumer access to overdose treatmentThe FDA announced approval of a new over-the-counter naloxone nasal spray called Rextovy, delivering 4 mg of naloxone hydrochloride for emergency reversal of opioid overdose. The product can be pu…
- Biotech Converts Failed Trial Data into AI ModelA biotech startup recently faced a setback when a clinical trial did not achieve its primary goals. Rather than discarding the results, the company chose to analyze the data for new insights. The…